Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Varm Cosmo is a South Korean biotechnology company specializing in the development and manufacture of aesthetic medical devices and biopharmaceuticals. As a subsidiary of the Cosmo Group, the company leverages advanced chemical engineering expertise to produce its flagship Varm line of hyaluronic acid (HA) dermal fillers. These products utilize a proprietary cross-linking technology designed to optimize viscoelasticity and minimize side effects. Varm Cosmo is actively expanding its presence in the global medical aesthetics market, targeting both domestic and international distribution. The company's portfolio focuses on non-surgical facial rejuvenation and volume restoration through high-purity injectable solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Varm Cosmo.